Research, recommendations, and tools

The FoCUS consortium has been working for almost three years, thoroughly identifying challenges and designing solutions, involving the perspectives of diverse system stakeholders.

Precision Financing Strategies white paperPrecision Financing Strategies

This comprehensive white paper lays out the practices and tools that can help make durable therapies sustainable by the healthcare system.

Federal Policy Recommendations for Durable TherapiesPolicy suggestions

Six suggestions where we can evolve public policy to make the US healthcare financing and reimbursement system ready for innovative therapies.

FoCUS Compendium

Get the complete collection of white papers and research briefs in one PDF

White papers

The Role of Stop-Loss Insurance and Reinsurance in Managing Performance-Based Agreements

Precision Financing Solutions for Durable / Potentially Curative Therapies

Designing financial solutions to ensure affordable access to cures

Research briefs

Expedited Insurance

Payer Perspectives Survey

Pediatric Gene Therapy Launches

Patient-Caregiver Financial Themes

Medicaid Best Price

Clinical trials and investment trends for novel CAR-T and TCR therapies

Model Contracts for Innovative Oncology Therapies

Projections from the existing pipeline of cell and gene therapies

Role of COE networks in curative cellular oncology therapies

Stop-Loss Insurance or Reinsurance for Multiyear Contracts

Impact of Patient Mobility on Annuity/Performance-Based Contracting

Orphan Reinsurer Benefit Managers (ORBMs)

Impact of Actuarial Risk on Health Plans

Designing Precision Financing for Cures

Payer Segmentation for Precision Financing

Financing Mechanisms Payer Survey

Portfolio Analysis Modeling

Send feedback

We want to know what works for you, and what doesn't. Please share your thoughts with us!

Subscribe to news

Join our mailing list to keep up to date on Paying for Cures news and events.